» Articles » PMID: 19022245

ErbB Receptors and Cell Polarity: New Pathways and Paradigms for Understanding Cell Migration and Invasion

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2008 Nov 22
PMID 19022245
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The ErbB family of receptor tyrosine kinases is involved in initiation and progression of a number of human cancers, and receptor activation or overexpression correlates with poor patient survival. Research over the past two decades has elucidated the molecular mechanisms underlying ErbB-induced tumorigenesis, which has resulted in the development of effective targeted therapies. ErbB-induced signal transduction cascades regulate a wide variety of cell processes, including cell proliferation, apoptosis, cell polarity, migration and invasion. Within tumors, disruption of these core processes, through cooperative oncogenic lesions, results in aggressive, metastatic disease. This review will focus on the ErbB signaling networks that regulate migration and invasion and identify a potential role for cell polarity pathways during cancer progression.

Citing Articles

HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies.

Loeffler E, Ancel J, Dalstein V, Deslee G, Polette M, Nawrocki-Raby B Life (Basel). 2024; 14(1).

PMID: 38255679 PMC: 10820545. DOI: 10.3390/life14010064.


Circular RNA circEMB promotes osteosarcoma progression and metastasis by sponging miR-3184-5p and regulating EGFR expression.

Tan J, Yang B, Zhong H, Luo M, Su Z, Xie C Biomark Res. 2023; 11(1):3.

PMID: 36611218 PMC: 9825012. DOI: 10.1186/s40364-022-00442-9.


Prognostic Significance of Epidermal Growth Factor Receptor Expression in Distant Metastatic Melanoma from Primary Cutaneous Melanoma.

Lee K, Suh H, Lee M, Lee W, Chang S Ann Dermatol. 2021; 33(5):432-439.

PMID: 34616124 PMC: 8460484. DOI: 10.5021/ad.2021.33.5.432.


Blue-conversion of organic dyes produces artifacts in multicolor fluorescence imaging.

Kim D, Chang Y, Park S, Jeong M, Kwon Y, Zhou K Chem Sci. 2021; 12(25):8660-8667.

PMID: 34257864 PMC: 8246296. DOI: 10.1039/d1sc00612f.


MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma.

Yang M, Zhang T, Zhang Y, Ma X, Han J, Zeng K J Exp Clin Cancer Res. 2021; 40(1):166.

PMID: 33980265 PMC: 8114533. DOI: 10.1186/s13046-021-01965-z.